Effect of High-Intensity Focused Electromagnetic Therapy on Balance and Quality of Life in Patients With Multiple Sclerosis
- Sponsor
- Middle East University
- Study ID
- NCT07646912
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Not accepted
Interventions
- High-Intensity Focused Electromagnetic Therapy — DEVICEFor 8 weeks, two weekly sessions of High-Intensity Focused Electromagnetic Therapy will be used to induce supramaximal contractions to strengthen the central core stabilizers (rectus abdominis, transversus abdominis, and erector spinae)
- Balance Exercises — OTHERStandardized balance training including static stance variations, dynamic weight-shifting, perturbation training, and functional gait adjustments will be conducted for 30-45 minutes per session through three weekly sessions for a total duration of 8 weeks.
Study Details
Evaluate the effect of High-Intensity Focused Electromagnetic Therapy on dynamic balance, fall risk, core muscle function, and quality of life in patients with multiple sclerosis.
Key Dates
- First listed
- Jun 15, 2026
- Start date
- Jun 22, 2026
- Status verified
- Jun 2026
- Primary completion
- Oct 8, 2026
- Completion
- Oct 14, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Experimental groupPatients with multiple sclerosis who will receive High-Intensity Focused Electromagnetic Therapy targeted at the abdominal and paraspinal core musculature, combined with a specialized balance training program for 8 weeks
- Active Comparator: Control groupPatients with multiple sclerosis who will receive the standardized balance training program alone for 8 weeks.
Primary Outcome Measure
Balance [ Time Frame: Baseline and after 8 weeks ]
Central Contacts
- Saher Lotfy Elgayar, Ph.D+201020429911
- Mohammed Youssef Elhamrawy, Ph.D+201282805567
Find similar trials
Related Studies
- Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)Recruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Serum Auto-Antibodies in Neurological DiseasesEnrolling By Invitation · University of California, Davis · Sacramento, California
- Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- NARCOMS Registry: A Multiple Sclerosis RegistryRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas